ECJ Medicinal products for human use – Supplementary protection certificate – Regulation (EC) No 469/2009 – Article 13(1) – Concept of ‘first authorisation to place [a product] on the market in the Community’ – Authorisation issued by the Swiss Institute for Medicinal Products (Swissmedic) – Automatic recognition in Liechtenstein – Authorisation issued by the European Medicines Agency – Period of validity of a certificate
References: C-617/12, [2013] EUECJ C-617/12, [2014] EUECJ C-617/12
Links: Bailii, Bailii
Statutes: Regulation (EC) No 469/2009 13(1)
Last Update: 23 September 2020; Ref: scu.518452
